120 related articles for article (PubMed ID: 3499156)
1. Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis.
Wolf GT; Schmaltz S; Hudson J; Robson H; Stackhouse T; Peterson KA; Poore JA; McClatchey KD
Arch Otolaryngol Head Neck Surg; 1987 Nov; 113(11):1200-6. PubMed ID: 3499156
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
[TBL] [Abstract][Full Text] [Related]
3. Definite vs adjuvant radiotherapy. Comparative effects on lymphocyte subpopulations in patients with head and neck squamous carcinoma.
Wolf GT; Amendola BE; Diaz R; Lovett EJ; Hammerschmidt RM; Peterson KA
Arch Otolaryngol; 1985 Nov; 111(11):716-26. PubMed ID: 2932094
[TBL] [Abstract][Full Text] [Related]
4. Lymphokine production and lymphocyte subpopulations in patients with head and neck squamous carcinoma.
Wolf GT; Lovett EJ; Peterson KA; Beauchamp ML; Baker SR
Arch Otolaryngol; 1984 Nov; 110(11):731-5. PubMed ID: 6237633
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte phenotypes at tumor margins in patients with head and neck cancer.
Guo M; Rabin BS; Johnson JT; Paradis IL
Head Neck Surg; 1987; 9(5):265-71. PubMed ID: 2957343
[TBL] [Abstract][Full Text] [Related]
6. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
[TBL] [Abstract][Full Text] [Related]
7. T-cell subsets and natural killer cell function with squamous cell carcinoma of the head and neck.
Strome M; Clark JR; Fried MP; Rodliff S; Blazar BA
Arch Otolaryngol Head Neck Surg; 1987 Oct; 113(10):1090-3. PubMed ID: 3497652
[TBL] [Abstract][Full Text] [Related]
8. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
[TBL] [Abstract][Full Text] [Related]
9. An immunological outcome predictive score for head and neck carcinoma patients.
Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
[TBL] [Abstract][Full Text] [Related]
10. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
13. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
Wolf GT; Carey TE
J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
[TBL] [Abstract][Full Text] [Related]
14. CD8
Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Acta Otolaryngol; 1999 Mar; 119(2):281-4. PubMed ID: 10320092
[TBL] [Abstract][Full Text] [Related]
16. T-lymphocytes as a prognostic indicator in head and neck cancer.
Schuller DE; Rock RP; Rinehart JJ; Koolemans-Beynen AR
Arch Otolaryngol Head Neck Surg; 1986 Sep; 112(9):938-41. PubMed ID: 3488752
[TBL] [Abstract][Full Text] [Related]
17. Immunologic evaluation and prognosis in patients with head and neck cancer.
Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
[TBL] [Abstract][Full Text] [Related]
18. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
19. Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease.
Distel LV; Fickenscher R; Dietel K; Hung A; Iro H; Zenk J; Nkenke E; Büttner M; Niedobitek G; Grabenbauer GG
Oral Oncol; 2009 Oct; 45(10):e167-74. PubMed ID: 19576838
[TBL] [Abstract][Full Text] [Related]
20. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
